BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30362536)

  • 1. Tetrandrine, a novel inhibitor of ether-à-go-go-1 (Eag1), targeted to cervical cancer development.
    Wang X; Chen Y; Li J; Guo S; Lin X; Zhang H; Zhan Y; An H
    J Cell Physiol; 2019 May; 234(5):7161-7173. PubMed ID: 30362536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrandrine suppresses cervical cancer growth by inducing apoptosis in vitro and in vivo.
    Zhang H; Xie B; Zhang Z; Sheng X; Zhang S
    Drug Des Devel Ther; 2019; 13():119-127. PubMed ID: 30587932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression.
    Díaz L; Ceja-Ochoa I; Restrepo-Angulo I; Larrea F; Avila-Chávez E; García-Becerra R; Borja-Cacho E; Barrera D; Ahumada E; Gariglio P; Alvarez-Rios E; Ocadiz-Delgado R; Garcia-Villa E; Hernández-Gallegos E; Camacho-Arroyo I; Morales A; Ordaz-Rosado D; García-Latorre E; Escamilla J; Sánchez-Peña LC; Saqui-Salces M; Gamboa-Dominguez A; Vera E; Uribe-Ramírez M; Murbartián J; Ortiz CS; Rivera-Guevara C; De Vizcaya-Ruiz A; Camacho J
    Cancer Res; 2009 Apr; 69(8):3300-7. PubMed ID: 19351862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel anti-cancer mechanism of Nutlin-3 through downregulation of Eag1 channel and PI3K/AKT pathway.
    Wang X; Chen Y; Liu H; Guo S; Hu Y; Zhan Y; An H
    Biochem Biophys Res Commun; 2019 Sep; 517(3):445-451. PubMed ID: 31378368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitriol down-regulates human ether a go-go 1 potassium channel expression in cervical cancer cells.
    Avila E; García-Becerra R; Rodríguez-Rasgado JA; Díaz L; Ordaz-Rosado D; Zügel U; Steinmeyer A; Barrera D; Halhali A; Larrea F; Camacho J
    Anticancer Res; 2010 Jul; 30(7):2667-72. PubMed ID: 20682996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice.
    Wu JM; Chen Y; Chen JC; Lin TY; Tseng SH
    Cancer Lett; 2010 Jan; 287(2):187-95. PubMed ID: 19586712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative and proapoptotic effects of astemizole on cervical cancer cells.
    de Guadalupe Chávez-López M; Hernández-Gallegos E; Vázquez-Sánchez AY; Gariglio P; Camacho J
    Int J Gynecol Cancer; 2014 Jun; 24(5):824-8. PubMed ID: 24819656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astemizole inhibits cell proliferation in human prostate tumorigenic cells expressing ether à-go-go-1 potassium channels.
    Bernal-Ramos G; Hernández-Gallegos E; Vera E; Chávez-López MG; Zúñiga-García V; Sánchez-Pérez Y; Garrido E; Camacho J
    Cell Mol Biol (Noisy-le-grand); 2017 Dec; 63(12):11-13. PubMed ID: 29307346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eag1 Voltage-Dependent Potassium Channels: Structure, Electrophysiological Characteristics, and Function in Cancer.
    Wang X; Chen Y; Zhang Y; Guo S; Mo L; An H; Zhan Y
    J Membr Biol; 2017 Apr; 250(2):123-132. PubMed ID: 28160046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors.
    García-Quiroz J; García-Becerra R; Santos-Martínez N; Barrera D; Ordaz-Rosado D; Avila E; Halhali A; Villanueva O; Ibarra-Sánchez MJ; Esparza-López J; Gamboa-Domínguez A; Camacho J; Larrea F; Díaz L
    BMC Cancer; 2014 Oct; 14():745. PubMed ID: 25280486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short Hairpin RNA (shRNA) Ether à go-go 1 (Eag1) inhibition of human osteosarcoma angiogenesis via VEGF/PI3K/AKT signaling.
    Wu J; Wu X; Zhong D; Zhai W; Ding Z; Zhou Y
    Int J Mol Sci; 2012 Oct; 13(10):12573-83. PubMed ID: 23202914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eag1 Gene and Protein Expression in Human Retinoblastoma Tumors and its Regulation by pRb in HeLa Cells.
    Chávez-López MG; Zúñiga-García V; Castro-Magdonel BE; Vera E; Garrido E; Sánchez-Ramos J; Ponce-Castañeda MV; Cabrera-Muñoz ML; Escobar Y; Ortiz CS; Hernández-Gallegos E; Avalos-Fuentes A; Camacho J
    Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 31973216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells.
    García-Becerra R; Díaz L; Camacho J; Barrera D; Ordaz-Rosado D; Morales A; Ortiz CS; Avila E; Bargallo E; Arrecillas M; Halhali A; Larrea F
    Exp Cell Res; 2010 Feb; 316(3):433-42. PubMed ID: 19932096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of Ether à go-go 1 by shRNA inhibits osteosarcoma growth and cell cycle progression.
    Wu J; Zhong D; Fu X; Liu Q; Kang L; Ding Z
    Int J Mol Sci; 2014 Apr; 15(4):5570-81. PubMed ID: 24694542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of Eag1 Gene Inhibits Osteosarcoma Proliferation and Migration by Targeting STAT3-VEGF Pathway.
    Wu X; Chen Z; Zeng W; Zhong Y; Liu Q; Wu J
    Biomed Res Int; 2015; 2015():617316. PubMed ID: 26783521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eag1 channels as potential cancer biomarkers.
    Rodríguez-Rasgado JA; Acuña-Macías I; Camacho J
    Sensors (Basel); 2012; 12(5):5986-95. PubMed ID: 22778627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of a bisbenzylisoquinline alkaloid dauricine on HERG potassium channels.
    Zhao J; Lian Y; Lu C; Jing L; Yuan H; Peng S
    J Ethnopharmacol; 2012 Jun; 141(2):685-91. PubMed ID: 21920426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of voltage-gated potassium channels in cancer.
    Pardo LA; Contreras-Jurado C; Zientkowska M; Alves F; Stühmer W
    J Membr Biol; 2005 Jun; 205(3):115-24. PubMed ID: 16362499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASTEMIZOLE, AN INHIBITOR OF ETHER-À-GO-GO-1 POTASSIUM CHANNEL, INCREASES THE ACTIVITY OF THE TYROSINE KINASE INHIBITOR GEFITINIB IN BREAST CANCER CELLS.
    García-Quiroz J; González-González ME; Díaz L; Ordaz-Rosado D; Segovia-Mendoza M; Prado-García H; Larrea F; García-Becerra R
    Rev Invest Clin; 2019; 71(3):186-194. PubMed ID: 31184333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procyanidin B1, a novel and specific inhibitor of Kv10.1 channel, suppresses the evolution of hepatoma.
    Na W; Ma B; Shi S; Chen Y; Zhang H; Zhan Y; An H
    Biochem Pharmacol; 2020 Aug; 178():114089. PubMed ID: 32533968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.